ES2338098T3 - Terapia de combinacion de enfermedades respiratorias usando anticuerpos y agentes antiinflamatorios. - Google Patents

Terapia de combinacion de enfermedades respiratorias usando anticuerpos y agentes antiinflamatorios. Download PDF

Info

Publication number
ES2338098T3
ES2338098T3 ES01935002T ES01935002T ES2338098T3 ES 2338098 T3 ES2338098 T3 ES 2338098T3 ES 01935002 T ES01935002 T ES 01935002T ES 01935002 T ES01935002 T ES 01935002T ES 2338098 T3 ES2338098 T3 ES 2338098T3
Authority
ES
Spain
Prior art keywords
antibody
rsv
antibodies
agent
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES01935002T
Other languages
English (en)
Spanish (es)
Inventor
Gregory Prince
Leslie S. Johnson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MedImmune LLC
Virion Systems Inc
Original Assignee
MedImmune LLC
Virion Systems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MedImmune LLC, Virion Systems Inc filed Critical MedImmune LLC
Application granted granted Critical
Publication of ES2338098T3 publication Critical patent/ES2338098T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/11—Paramyxoviridae (F); Pneumoviridae (F), e.g. respiratory syncytial virus [RSV]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
ES01935002T 2000-05-03 2001-05-03 Terapia de combinacion de enfermedades respiratorias usando anticuerpos y agentes antiinflamatorios. Expired - Lifetime ES2338098T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20140400P 2000-05-03 2000-05-03
US201404P 2000-05-03

Publications (1)

Publication Number Publication Date
ES2338098T3 true ES2338098T3 (es) 2010-05-04

Family

ID=22745679

Family Applications (1)

Application Number Title Priority Date Filing Date
ES01935002T Expired - Lifetime ES2338098T3 (es) 2000-05-03 2001-05-03 Terapia de combinacion de enfermedades respiratorias usando anticuerpos y agentes antiinflamatorios.

Country Status (9)

Country Link
US (2) US7208162B2 (de)
EP (1) EP1278546B1 (de)
JP (1) JP2003531867A (de)
AT (1) ATE457177T1 (de)
AU (2) AU2001261137B2 (de)
CA (1) CA2407292A1 (de)
DE (1) DE60141274D1 (de)
ES (1) ES2338098T3 (de)
WO (1) WO2001082966A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2398466A1 (en) * 2000-01-27 2001-08-02 Medimmune, Inc. Ultra high affinity neutralizing antibodies
JP2003525061A (ja) * 2000-03-01 2003-08-26 メディミューン，インコーポレイテッド 高効力組換え抗体およびその産生法
CA2407292A1 (en) 2000-05-03 2001-11-08 Medimmune, Inc. Combination therapy of respiratory diseases using antibodies and anti-inflammatory agents
US6855493B2 (en) * 2000-11-28 2005-02-15 Medimmune, Inc. Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
US7179900B2 (en) * 2000-11-28 2007-02-20 Medimmune, Inc. Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
US20040096451A1 (en) * 2002-07-25 2004-05-20 Young James F. Methods of treating and preventing RSV, hMPV, and PIV using anti-RSV, anti-hMPV, and anti-PIV antibodies
GB2388194A (en) * 2002-05-02 2003-11-05 Nec Technologies Remote medical monitor utilising a mobile telephone
US7132100B2 (en) * 2002-06-14 2006-11-07 Medimmune, Inc. Stabilized liquid anti-RSV antibody formulations
US7425618B2 (en) * 2002-06-14 2008-09-16 Medimmune, Inc. Stabilized anti-respiratory syncytial virus (RSV) antibody formulations
KR101224235B1 (ko) 2003-04-11 2013-01-25 메디뮨 엘엘씨 재조합 ｉｌ­９ 항체 및 그의 용도
US20060035859A1 (en) * 2003-05-16 2006-02-16 Hemispherx Biopharma Treating severe and acute viral infections
WO2006041970A2 (en) * 2004-10-08 2006-04-20 Abbott Biotechnology Ltd. Treatment of respiratory syncytial virus (rsv) infection
CA2585891A1 (en) * 2004-10-29 2006-05-11 Medimmune, Inc. Methods of preventing and treating rsv infections and related conditions
WO2008019061A2 (en) * 2006-08-03 2008-02-14 Vaccinex, Inc. Anti-il-6 monoclonal antibodies and uses thereof
EP1997830A1 (de) 2007-06-01 2008-12-03 AIMM Therapeutics B.V. RSV-spezifische Bindemoleküle und Mittel zu ihrer Herstellung
US8568726B2 (en) 2009-10-06 2013-10-29 Medimmune Limited RSV specific binding molecule
WO2018075954A2 (en) 2016-10-21 2018-04-26 Adimab, Llc Anti-respiratory syncytial virus antibodies, and methods of their generation and use
AU2017345786B2 (en) 2016-10-21 2024-08-01 Adimab, Llc Anti-respiratory syncytial virus antibodies, and methods of their generation and use
US11312761B2 (en) 2016-10-21 2022-04-26 Adimab, Llc Anti-respiratory syncytial virus antibodies, and methods of their generation and use
WO2021226479A1 (en) * 2020-05-07 2021-11-11 The Regents Of The University Of California Inhaled statins for treatment of viral respiratory diseases
IL328264A (en) 2023-11-14 2026-07-01 Janssen Pharmaceuticals Inc Anti-Respiratory Syncytial Virus Antibodies and Their Uses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06507404A (ja) * 1991-05-01 1994-08-25 ヘンリー　エム．ジャクソン　ファウンデイション　フォー　ザ　アドバンスメント　オブ　ミリタリー　メディスン 感染性の呼吸性疾患の治療方法
US5824307A (en) * 1991-12-23 1998-10-20 Medimmune, Inc. Human-murine chimeric antibodies against respiratory syncytial virus
JP2002521334A (ja) * 1998-07-20 2002-07-16 ブリストルーマイヤーズ スクイブ カンパニー 置換ベンズイミダゾール抗ウィルス剤
CA2407292A1 (en) 2000-05-03 2001-11-08 Medimmune, Inc. Combination therapy of respiratory diseases using antibodies and anti-inflammatory agents

Also Published As

Publication number Publication date
WO2001082966A1 (en) 2001-11-08
CA2407292A1 (en) 2001-11-08
EP1278546A1 (de) 2003-01-29
JP2003531867A (ja) 2003-10-28
AU2001261137B2 (en) 2006-05-25
ATE457177T1 (de) 2010-02-15
US20070224204A1 (en) 2007-09-27
DE60141274D1 (de) 2010-03-25
AU6113701A (en) 2001-11-12
US20020051787A1 (en) 2002-05-02
EP1278546B1 (de) 2010-02-10
US7208162B2 (en) 2007-04-24
AU2001261137C1 (en) 2001-11-12

Similar Documents

Publication Publication Date Title
US20070224204A1 (en) Combination therapy of respiratory diseases using antibodies and anti-inflammatory agents
Parray et al. Inhalation monoclonal antibody therapy: a new way to treat and manage respiratory infections
AU666852B2 (en) A method for treating infectious respiratory diseases
AU2001261137A1 (en) Combination therapy of respiratory diseases using antibodies and anti-inflammatory agents
Prince et al. Effectiveness of topically administered neutralizing antibodies in experimental immunotherapy of respiratory syncytial virus infection in cotton rats
US8273354B2 (en) Anti-RSV G protein antibodies
AU2001259379B2 (en) Combination therapy of respiratory diseases using antibodies
PT1159003E (pt) Anti-tnf alfa na terapêutica da asma resistente a esteróides
AU2001259379A1 (en) Combination therapy of respiratory diseases using antibodies
ES2360334T3 (es) Composiciones farmacéuticas de anticuerpos para enfermedades causadas por virus.
US20220025019A1 (en) Methods and compositions for preventing or treating acute exacerbations with polyclonal immunoglobulin
AU2006203171B2 (en) Combination therapy of respiratory diseases using antibodies and anti-inflammatory agents
USRE38071E1 (en) Method for treating infectious respiratory diseases
AU2008201412A1 (en) Combination therapy of respiratory diseases using antibodies and anti-inflammatory agents
EP4107186A1 (de) Tocilizumab- und remdesivir-kombinationstherapie für covid-19-pneumonie
TW202337497A (zh) 鼻內調配物及抗sars-cov-2棘蛋白抗體
ES2357749T3 (es) Anticuerpos anti-tnf alfa en la terapia del asma resistente a esteroides.
EP4507720A1 (de) Alpha-1-antitrypsin zur behandlung von paramyxoviridae- oder orthomyxoviridae-infektionen
JP2025518050A (ja) 吸入可能治療薬のための組成物および方法
EP4655072A1 (de) Verfahren zur prävention oder behandlung von coronavirus-infektionen
CHANOCK Infection in Cotton Rats